Neuroprotective subthalamotomy in Parkinson's disease. The role of magnetic resonance-guided focused ultrasound in early surgery
Guridi J (1), Marigil M [SP] (2), Becerra V (2), Parras O (2).
(1) Servicio de Neurocirugía Clínica, Universidad de Navarra, Pamplona, España.
(2) Servicio de Neurocirugía Clínica, Universidad de Navarra, Pamplona, España.
Date: May 5, 2016Neurosurgery
Subthalamic nucleus hyperactivity in Parkinson's disease may be a very early phenomenon. Its start is not well known, and it may occur during the pre-symptomatic disease stage.
Glutamatergic hyperactivity may be neurotoxic over the substantia nigra compacta dopaminergic neurons. If this occurred, the excitatory neurotransmitter, glutamate, should affect the neurons that maintain a high turnover as a compensatory mechanism. Would a subthalamic nucleus lesion decrease this hyperactivity and thus be considered as a neuroprotective mechanism for dopaminergic neurons?
The authors hypothesise about the possibility to perform surgery on a subthalamic nucleus lesion at a very early stage in order to avoid the neurotoxic glutamatergic effect over the dopaminergic neurons, and therefore be considered as a neuroprotective surgery able to alter the progress of the disease during early motor symptoms.
In this regard, magnetic resonance-guided focused ultrasound techniques open a new window in the stereotactic armamentarium.
CITATION Neurocirugia (Astur). 2016 May 5. pii: S1130-1473(16)00035-X. doi: 10.1016/j.neucir.2016.02.006
you maybe interested
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.